NCT06645158View on ClinicalTrials.gov

TCB Self-Monitoring in Healthy Term and Near-Term Neonates

CompletedOBSERVATIONAL
Enrollment

220,950

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

July 1, 2025

Conditions
Hyperbilirubinemia, Neonatal
Interventions
DEVICE

Transcutaneous bilirubin level monitoring

self-monitoring by parents long-term: from birth to 30 days of age

Trial Locations (1)

510120

Guangzhou Women and Children's Medical Center,, Guangzhou

All Listed Sponsors
collaborator

Guangzhou Women and Children's Medical Center

OTHER

lead

Neonatal-Infant Brain and Behavior Development Network

NETWORK

NCT06645158 - TCB Self-Monitoring in Healthy Term and Near-Term Neonates | Biotech Hunter | Biotech Hunter